Fawzi Aljassir

Fawzi Aljassir

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fawzi Aljassir has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Extraarticular Pretibial Synovial Cyst After Arthroscopic Anterior Cruciate Ligament Reconstruction: A Case Report

    by Rheema Alfadhil, Ibrahim Alshaygy, Fawzi Aljassir

    Arthroscopic reconstruction of the anterior cruciate ligament has been modernized through new materials and novel surgical techniques. The usage of bioabsorbable screws for tibial fixation may potentially lead to complications, such as formation of a tibial tunnel or pretibial cysts. This is a relatively rare complication, but it has been described in the literature. The pathomechanism of cyst formation, however, still remains poorly understood. In this case report, we present a case of a healthy 23-year-old gentleman who had left tibia vara, which was treated surgically with proximal tibia corrective osteotomy with plate and screw fixation and subsequent hardware removal. Later in his life, he injured his anterior cruciate ligament, which required arthroscopic reconstruction. Years after, he developed a pretibial synovial cyst, which was visualized on magnetic resonance imaging. We reviewed previously published cases with similar presentations to help describe the possible etiology of intraosseous (tibial tunnel) cysts.


  • Open Access

    In vitro assessment of Function Graded (FG) artificial Hip joint stem in terms of bone/cement stresses: 3D Finite Element (FE) study

    by Fawzi F Al-Jassir, H Fouad, Othaman Y Alothman

    Stress shielding in the cemented hip prosthesis occurs due to the mismatching in the mechanical properties of metallic stem and bone. This mismatching in properties is considered as one of the main reasons for implant loosening. Therefore, a new stem material in orthopedic surgery is still required. In the present study, 3D finite element modeling is used for evaluating the artificial hip joint stem that is made of Function Graded (FG) material in terms of joint stress distributions and stem length. 3D finite element models of different stems made of two types of FG materials and traditional stems made of Cobalt Chromium alloy (CoCrMo) and Titanium alloy (Ti) were developed using the ANSYS Code. The effects on the total artificial hip joint stresses (Shear stress and Von Mises stresses at bone cement, Von Mises stresses at bone and stem) due to using the proposed FG materials stems were investigated. The effects on the total artificial hip joint system stresses due to using different stem lengths were investigated. Using FG stem (with low stiffness at stem distal end and high stiffness at its proximal end) resulted in a significant reduction in shear stress at the bone cement/stem interface. Also, the Von Mises stresses at the bone cement and stem decrease significantly when using FG material instead of CoCrMo and Ti alloy. The stresses’ distribution along the bone cement length when using FG material was found to be more uniform along the whole bone cement compared with other stem materials. These more uniform stresses will help in the reduction of the artificial hip joint loosening rate and improve its short and long term performance. FE results showed that using FG stem increases the resultant stresses at the femur bone (reduces stress shielding) compared to metallic stem. The results showed that the stem length has significant effects on the resultant shear and Von Mises stresses at bone, stem and bone cement for all types of stem materials.


  • Open Access

    Articular cartilage changes associated with bony contusions in anterior cruciate ligament injury

    by Fawzi F. Al-Jassir, Monica Volesky, Eric Lenczner, Mark Burman

  • Open Access

    Human Stromal (Mesenchymal) Stem Cells from Bone Marrow, Adipose Tissue and Skin Exhibit Differences in Molecular Phenotype and Differentiation Potential

    by May Al-Nbaheen, Radhakrishnan Vishnubalaji, Dalia Ali, Amel Bouslimi, Fawzi Al-Jassir, Matthias Megges, Alessandro Prigione, James Adjaye, Moustapha Kassem, Abdullah Aldahmash

    Human stromal (mesenchymal) stem cells (hMSCs) are multipotent stem cells with ability to differentiate into mesoderm-type cells e.g. osteoblasts and adipocytes and thus they are being introduced into clinical trials for tissue regeneration. Traditionally, hMSCs have been isolated from bone marrow, but the number of cells obtained is limited. Here, we compared the MSC-like cell populations, obtained from alternative sources for MSC: adipose tissue and skin, with the standard phenotype of human bone marrow MSC (BM-MSCs). MSC from human adipose tissue (human adipose stromal cells (hATSCs)) and human skin (human adult skin stromal cells, (hASSCs) and human new-born skin stromal cells (hNSSCs)) grew readily in culture and the growth rate was highest in hNSSCs and lowest in hATSCs. Compared with phenotype of hBM-MSC, all cell populations were CD34−, CD45−, CD14−, CD31−, HLA-DR−, CD13+, CD29+, CD44+, CD73+, CD90+,and CD105+. When exposed to in vitro differentiation, hATSCs, hASSCs and hNSSCs exhibited quantitative differences in their ability to differentiate into adipocytes and to osteoblastic cells. Using a microarray-based approach we have unveiled a common MSC molecular signature composed of 33 CD markers including known MSC markers and several novel markers e.g. CD165, CD276, and CD82. However, significant differences in the molecular phenotype between these different stromal cell populations were observed suggesting ontological and functional differences. In conclusion, MSC populations obtained from different tissues exhibit significant differences in their proliferation, differentiation and molecular phenotype, which should be taken into consideration when planning their use in clinical protocols.